SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
1.216
-0.024 (-1.94%)
Nov 21, 2024, 12:38 PM EST - Market open

SLS Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Revenue
--17.61.9-
Upgrade
Revenue Growth (YoY)
---86.84%300.00%--
Upgrade
Cost of Revenue
--0.10.2--
Upgrade
Gross Profit
--0.97.41.9-
Upgrade
Selling, General & Admin
13.0213.8612.5811.329.69.92
Upgrade
Research & Development
19.7624.0120.2715.679.287.29
Upgrade
Operating Expenses
32.7737.8732.8526.9918.8817.21
Upgrade
Operating Income
-32.77-37.87-31.95-19.59-16.98-17.21
Upgrade
Interest & Investment Income
0.490.530.320.010.030.12
Upgrade
Other Non Operating Income (Expenses)
-00.040.02-0.11.14
Upgrade
EBT Excluding Unusual Items
-32.28-37.34-31.6-19.57-17.05-15.95
Upgrade
Other Unusual Items
--0.34.340.28-0.59
Upgrade
Pretax Income
-32.28-37.34-41.3-20.94-16.77-19.37
Upgrade
Income Tax Expense
----0.24-0.02-0.08
Upgrade
Net Income
-32.28-37.34-41.3-20.7-16.76-19.29
Upgrade
Preferred Dividends & Other Adjustments
----0.088.66
Upgrade
Net Income to Common
-32.28-37.34-41.3-20.7-16.84-27.95
Upgrade
Shares Outstanding (Basic)
5028191583
Upgrade
Shares Outstanding (Diluted)
5028191583
Upgrade
Shares Change (YoY)
99.45%43.21%25.29%94.07%211.76%878.33%
Upgrade
EPS (Basic)
-0.64-1.34-2.13-1.34-2.11-10.92
Upgrade
EPS (Diluted)
-0.64-1.34-2.13-1.34-2.11-10.92
Upgrade
Free Cash Flow
-33.07-31.41-23.81-26.02-10.42-17.64
Upgrade
Free Cash Flow Per Share
-0.66-1.13-1.23-1.68-1.31-6.90
Upgrade
Gross Margin
--90.00%97.37%100.00%-
Upgrade
Operating Margin
---3195.00%-257.82%-893.79%-
Upgrade
Profit Margin
---4130.10%-272.36%-886.05%-
Upgrade
Free Cash Flow Margin
---2380.90%-342.38%-548.26%-
Upgrade
EBIT
-32.77-37.87-31.95-19.59-16.98-17.21
Upgrade
EBIT Margin
----257.82%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.